Abstract The blocker of receptor-mediated calcium entry SK&F 96365 was used to evaluate the contribution of calcium influx to the formation of biologically active endothelial prostanoids and endothelium-derived relaxing factor (EDRF). SK&F 96365 inhibited histamine-stimulated calcium entry into human umbilical vein endothelial cells but not its discharge from intracellular stores as determined spectrofluorometrically by changes of intracellular calcium concentration in fura-2-loaded cells. Concordantly, SK&F 96365 inhibited histamine-induced endothelial synthesis of 6-keto-prostaglandin F la and thromboxane B, in a dose-dependent manner. To assess the functional significance of endothelial formation of prostacyclin and EDRF to platelets, the cAMP-and cGMPdependent phosphorylation of two platelet proteins, raplB and a 50-kD vasodilator-stimulated phosphoprotein (VASP), was analyzed in coincubation experiments of endothelial cells with platelets. Autacoids released by histamine-stimulated E ndothelium-derived autacoids are crucial for the maintenance of local vascular homeostasis and endothelium-platelet interactions. Endothelial cells (ECs) respond to hormonal, chemical, and physical stimuli with the generation and release of prostacyclin and endothelium-derived relaxing factor (EDRF; nitric oxide or nitric oxide-releasing compounds), both of which are known to dilate vessels and inhibit platelet function in a paracrine manner. 15 Concomitantly, ECs also release the potent vasoconstrictor and stimulator of platelet aggregation thromboxane A 2 (TXA 2 ).
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Abstract The blocker of receptor-mediated calcium entry SK&F 96365 was used to evaluate the contribution of calcium influx to the formation of biologically active endothelial prostanoids and endothelium-derived relaxing factor (EDRF). SK&F 96365 inhibited histamine-stimulated calcium entry into human umbilical vein endothelial cells but not its discharge from intracellular stores as determined spectrofluorometrically by changes of intracellular calcium concentration in fura-2-loaded cells. Concordantly, SK&F 96365 inhibited histamine-induced endothelial synthesis of 6-keto-prostaglandin F la and thromboxane B, in a dose-dependent manner. To assess the functional significance of endothelial formation of prostacyclin and EDRF to platelets, the cAMP-and cGMPdependent phosphorylation of two platelet proteins, raplB and a 50-kD vasodilator-stimulated phosphoprotein (VASP), was analyzed in coincubation experiments of endothelial cells with platelets. Autacoids released by histamine-stimulated E ndothelium-derived autacoids are crucial for the maintenance of local vascular homeostasis and endothelium-platelet interactions. Endothelial cells (ECs) respond to hormonal, chemical, and physical stimuli with the generation and release of prostacyclin and endothelium-derived relaxing factor (EDRF; nitric oxide or nitric oxide-releasing compounds), both of which are known to dilate vessels and inhibit platelet function in a paracrine manner. 15 Concomitantly, ECs also release the potent vasoconstrictor and stimulator of platelet aggregation thromboxane A 2 (TXA 2 ). 6 ' 7 The increase of cytosolic calcium concentration ([Ca 2+ ],), a key step in the stimulus-response coupling of ECs, leads to the activation of calcium-dependent enzymes such as phospholipase A 2 and nitric oxide synthase. 89 A variety of blood-borne mediators interact with endothelial surface receptors and raise [Ca 2+ ], by both inducing second messenger-mediated discharge of calcium from internal stores and promoting influx from the extracellular milieu.
1 Calcium entry into nonexcitable cells occurs voltage independently via receptorcoupled channels of the plasma membrane that are not well characterized. 10 Formation and release of EDRF and prostanoids by the vascular endothelium are coupled to an increase in [Ca 2+ ],. 8 -9 However, the synthesis of both autacoids may be differentially regulated by intracellular calcium. Whereas EDRF generation critically depends on agonist-induced calcium entry, 11 ' 12 calcium-dependent and calcium-independent pathways for prostacyclin release have been described. 111315 In the present study we used the inhibitor of receptoroperated calcium influx SK&F 96365 16 to investigate the contribution of receptor-mediated calcium entry to the biosynthesis of prostacyclin and TXA 2 from cultured ECs. To assess the biological relevance of endotheliumderived vasodilators (prostacyclin and EDRF) for platelets, the cAMP-and cGMP-dependent phosphorylation of two platelet proteins, raplB 17 and a 50-kD vasodilator-stimulated phosphoprotein (VASP), 18 - 19 was studied in coincubation experiments of human umbilical vein ECs with human platelets.
ary fluorcscein-labeled antibodies from sheep against mouse immunoglobulin G were from Boehringer.
Cell Culture Medium
Medium 199 (GIBCO BRL) was supplemented with 10% human serum, gentamicin sulfate (50 jig/mL) (both from Serva), 10% fetal calf serum (FCS), L-glutamine (2 mmol/L), sodium pyruvate (1 mmol/L), HEPES (10 mmol/L), 1% nonessential amino acids, heparin (75 /ig/mL) (all from Sigma), aiscorbate and glutathione (2.5 /ig/mL each; Biochrom), and EC growth factor (25 /xg/mL; Boehringer).
Human Umbilical Vein EC Culture
Human umbilical cords were obtained from term pregnancies and ECs were prepared as described by Jaffe et al 20 with minor modifications. Briefly, enzymatic disaggregation of ECs was performed by filling cord veins with 0.1% o-chymotrypsin for 25 minutes at 37°C. After rinsing the veins with phosphatebuffered saline (PBS) containing 5% FCS, the cell suspension was centrifuged at 800g for 8 minutes and resuspended in complete culture medium. Cells were seeded into culture flasks (Bibby Dunn) precoated with collagen and grown to confluence at 37°C in a humidified atmosphere with 5% CO 2 and 95% air. Confluent primary cultures were detached with 0.1% trypsin and reseeded into T-75 flasks. Passages 3 through 5 were used for the experiments. Cells were identified as ECs under phase-contrast microscopy (typical "cobblestone" morphology); indirect immunofluorescence shows positive staining for human factor VIII antigen and negative staining for a-actin, a marker for smooth muscle cells.
Pig Coronary Artery Rings
Hearts from adult pigs were prepared 1 hour after slaughter. After carefully dissecting the left anterior descending and circumflex arteries and removing any adhering tissue, the vessels were rinsed with PBS and cut into equal-sized rings of about 1 mm. The rings were thoroughly rinsed of red blood cells to remove hemoglobin and weighed, and equal portions of about 10 pieces were placed in reagent tubes in prewarmed buffer (see below) prior to the coincubation experiment.
Calcium Measurement
For measurement of [Ca 2+ ],, ECs were grown to confluence on 1.9-cm 2 regular microscope glass coverslips (7x10* cells/ coverslip) precoated with PepTite 2000 (Biomol). Fluorometry of fura-2 was used to measure [Ca 2+ ], by using a modified standard method as previously described for coronary smooth muscle cells. 21 In brief, dye loading was performed after placing coverslips in 8-multiwell plates (Nunc) and covering them with 1.5 mL medium 199 containing 20 mmol/L HEPES and 5 jimol/L fura 2-AM at 37°C for 45 minutes. Thereafter the cells were kept in the dark at room temperature. To remove extracellular dye, coverslips were rinsed three times with a buffer (pH 7.4) containing (in mmol/L) 145 NaCl, 5 KC1, 0. Human platelets were isolated from freshly drawn whole blood and labeled with [^PJorthophosphate. 24 After labeling, platelets (4X10 3 platelets/fiL) were resuspended in 15 mL buffer (in mmol/L: 20 HEPES, 138 NaCl, 2.9 KC1, 1 MgCl 2 , 0.36 NaH 2 PO 4 , 5 glucose, and 10 /iniol/L CaCl 2 ; pH 7.4) that contained apyrase (0.6 U/mL ADPase) but no platelet-poor plasma and EGTA. ECs were grown to confluence in 6-well plates (6 to 7X10 5 cells/well) in supplemented medium 199. The cells were rinsed two times with warmed buffer (see description under "Calcium Measurement") plus 1 mmol/L Ca 2+ and were preincubated in the same buffer (1 mL/well) for 60 minutes at 37°C with or without either 10 /xmol/L indomethacin, 1 mmol/L L-NMMA, or both. Endothelial monolayers and pig coronary artery rings were pretreated with SK&F 96365 for 2 minutes prior to stimulation with 1 /imol/L histamine (ECs) or 1 jtmol/L bradykinin (coronary artery rings). Histamine and bradykinin were chosen to selectively stimulate ECs without activating platelets in the coincubation. Coincubations were initiated 1 minute after stimulation by addition of the platelet suspension (2x10* cells in 0.5 mL buffer; final concentration, 1.3xl0VmL; platelet/EC ratio, approximately 300:1) to the EC monolayers and pig coronary artery rings. At the indicated times, aliquots (0.1 mL) of the platelet suspension were transferred into 0.1 mL of electrophoresis sample buffer.
Protein Gel Electrophoresis and Autoradiographŷ
-labeled proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using the 20-cmlong vertical system from BioRad. A 1.5-mm-thick 10% polyacrylamide running gel with a 4% stacking gel was used. After electrophoresis, the gel front and stacking gel were cut from the running gel and discarded. The running gel was stained with Coomassie Blue R-250, dried, and exposed to Kodak X-OMAT-AR film at -80°C. Bands corresponding to the phosphorylated 50-kD protein VASP and raplB were measured by laser densitometry (UltroScan XL, Pharmacia).
Statistics
Unless indicated otherwise, the data are reported as mean±SEM. Statistical evaluation was performed with the Mann-Whitney U test. A value of P<.05 was considered statistically significant. ]i peak could be attributed to Ca 2+ discharge from internal stores since the removal of external Ca 2+ and the addition of 0.2 mmol/L EGTA to the buffer abolished the sustained phase but only slightly attenuated the peak response to histamine ( Fig 1C and Table 1 ). Subsequent addition of 1.5 mmol/L Ca 2+ to the same cells in the presence of histamine restored the plateau phase, which is representative of Ca 2+ influx (Fig 1C) . The inhibitor of receptor-operated Ca 2+ influx SK&F 96365 prevented the plateau when added after stimulation with histamine in a nominally Ca 2+ -free buffer prior to supplementation of 1.5 mmol/L Ca 2+ (Fig ID) .
Results

Effects of Various
In platelets, 100 /imol/L SK&F 96365 markedly attenuated internal Ca 2+ release, whereas 25 /xmol/L SK&F 96365 inhibited about 90% of Ca 2+ entry but only 10% of Ca 2+ release. 16 In this study preincubation of ECs with 25 /xmol/L SK&F 96365 for 2 minutes before stimulation with either 1 ^.mol/L or 10 junol/L histamine only slightly reduced the [Ca 2+ ] ( peak but substantially attenuated the plateau (Fig 1A and IB, ]i plateau (Fig IE and IF) . A maximal reduction of the plateau of 91% could be achieved with 100 jimol/L SK&F 96365 (not shown).
In 
Effects of Various Substances on Histamine-Induced Prostanoid Release
Treatment of ECs with 1 ^unol/L histamine for 20 minutes produced 8.7±1.1-and 3.0±0.6-fold increases of 6-keto-PGF la and TXB2 release, respectively. After a 60-minute preincubation with 1 mmol/L L-NMMA and 10 /unol/L indomethacin (inhibitors of EDRF formation and PGI 2 synthesis, respectively), prostanoid production did not change with the former but was markedly suppressed with the latter, as expected (Table 2) . SK&F 96365 dose dependently suppressed 6-keto-PGF la and TXBj release with a calculated EQo of approximately 2 Atmol/L for 6-keto-PGF la and 0.9 jimol/L for TXB? (Fig  2) . Pretreatment with 25 fimolfL SK&F 96365 for 2 minutes suppressed the histamine-stimulated synthesis of 6-keto-PGF la by 84±5% and that of TXBj by 86±3% (Table 2 ). In contrast, a 5-minute pretreatment with the L-type Ca ]i measurements, SK&F 96365 had no effect on A 23187-induced 6-keto-PGF,,, release. A 23187 at 1 /j,mol/L stimulated the release of 6-keto-PGF la 16 .3±4.8-fold in the absence and 14.9±3.9-fold in the presence of SK&F 96365 (difference not significant). To determine whether extracellular Ca 2+ was necessary for histamine-induced prostanoid release, ECs were placed in a nominally Ca 2+ -free buffer (with 0.2 mmol/L EGTA) and stimulated with histamine. Under this condition basal prostanoid release was slightly reduced, and the histamine-stimulated release was significantly sup- Hlstamlne+EGTA, 02 mmol/L 6-Keto-PGF, 0 Indicates 6-ketoprostaglandin F 1(I ; TXB2, thromboxane B2; and ND, not determined. Data are mean±SEM of triplicate determinations of three single experiments. Cells were pretreated with N G -monomethyl-L-arginine (L-NMMA) and Indomethacin for 60 minutes, with nitrendipine for 5 minutes, and with SK&F 96365 for 2 minutes before addition of 1 ycmo\IL histamine. Cells were then stimulated for 20 minutes in a buffer containing 1 mmol/L calcium, except for the EGTA experiment during which no extracellular calcium was present. Neither nitrendipine, SK&F 96365, nor 0.1% ethanol, the solvent of nitrendipine and indomethacin, Influenced basal release of prostanolds (all other drugs were dissolved in water). 6-Keto-PGF,,, and TXB 2 were assayed by radioimmunoassay. *P<.001, tf<05 versus basal.
pressed to an extent comparable to that after SK&F 96365 pretreatment (Table 2) .
EC-Platelet Coincubation: Phosphorylation of Platelet raplB and VASP
Stimulation of ECs with histamine (1 ^.mol/L) induced a time-dependent phosphorylation of platelet VASP and raplB in coincubation experiments (Fig 3) . The phosphorylation of VASP was rapid, transient, and less pronounced than the marked phosphorylation of raplB, which was slow and persisted for more than 2 hours (Fig 4 and data not shown) . The maximal phosphorylation of VASP and raplB was 3.2±0.4-and 
VASP (data not shown). Preincubation of ECs with
indomethacin, L-NMMA, or both 60 minutes before coincubation with platelets decreased the endotheliumdependent phosphorylation of VASP and raplB (Fig 4 and Table 3 ). The inhibitory effect of indomethacin was more pronounced than that of L-NMMA. Pretreatment of ECs with SK&F 96365 for 2 minutes before stimulation with histamine caused a marked inhibition of the phosphorylation of both platelet proteins. The effect of SK&F 96365 was comparable to that of the combination of indomethacin and L-NMMA (Fig 4 and Table 3 ). No effect of indomethacin, L-NMMA, or SK&F 96365 on platelet VASP and raplB phosphorylation was found in the absence of ECs (data not shown). Analogous experiments were conducted in a coincubation system of pig coronary artery rings and platelets. Coronary artery rings were pretreated with SK&F 96365 for 2 minutes and were subsequently stimulated with 1 jimol/L bradykinin (Fig 5) . The inhibitory effect of SK&F 96365 on protein phosphorylation was comparable to that in the venous EC-platelet coincubation experiments. SK&F 96365 inhibited phosphorylation of VASP by 56.7% and that of raplB by 76.6% (compare Figs 4 and 5) .
A proposed model of the inhibitory action of SK&F 96365 on endothelial autacoid formation and on vasodilator-dependent platelet VASP and rap IB phosphorylation is shown in Fig 6. No stimulation of phosphorylation of pleckstrin, the substrate of protein kinase C, or myosin light chain, the substrate of Ca 2+ /calmodulindependent myosin light chain kinase, could be detected in coincubations of platelets with either ECs (Fig 3) or coronary artery rings (not shown). In contrast, the phosphorylation of these proteins was rapidly suppressed after exposing platelets to histamine-stimulated ECs. These results indicate that the platelet-inhibiting effect of PGI 2 and EDRF predominated over the platelet-activating effect of TXA 2 , which is concomitantry released from stimulated ECs.
Discussion
The objective of this study was to determine the contribution of extracellular calcium entry to endothelial biosynthesis of prostacyclin and TXA 2 and to assess the functional consequence of a pharmacological blockade of receptor-mediated calcium entry by SK&F 96365 on endothelium-platelet interactions. The biological net effect of endothelial autacoid release was determined in coincubation experiments of histamine-stimulated ECs and human platelets. The measurement of platelet protein phosphorylation was used to indicate if platelets were activated or inhibited. Specifically, the phosphorylation of raplB and VASP served as a biological marker for the action of cAMP-and cGMP-increasing prostacyclin and EDRF, respectively. The data demonstrate that the blockade of receptor-operated calcium entry by SK&F 96365 markedly prevented histaminestimulated formation of PGI 2 and TXA 2 by cultured ECs. Moreover, inhibition of this calcium influx prevented the biosynthesis and subsequent biological action of prostacyclin and EDRF on platelet raplB and VASP phosphorylation.
Calcium entry in nonexcitable cells has been proposed to occur via mechanisms directly coupled to the ligand-binding site, to be mediated by G proteins, to be facilitated by intracellular second messengers, or to depend on the state of filling of internal calcium stores. 10 The inhibitor of receptor-operated calcium influx SK&F 96365 is active in a variety of mammalian cells including human platelets and neutrophils, 16 eosinophils, 23 smooth muscle cells, 26 neuronal cells, 27 and ECs of different species. 16 - 28 Our results in ECs demonstrate that SK&F 96365 blocks calcium entry when administered both before and after stimulation with histamine, which suggests that the compound does not interfere with the binding of histamine with its receptor. Moreover, the inhibitory effect of SK&F 96365 when added 4 minutes after stimulation indicates that the compound blocks calcium entry through channels that are still open at that time. Effects on the inositol 1,4,5-trisphosphate (InsP 3 )-dependent internal calcium release, represented by the initial [Ca 2+ ]i peak after histamine stimulation, were negligible with the chosen concentration of SK&F 96365. Besides its effects on histamine, SK&F 96365 blocks the calcium influx in response to different agonists such as bradykinin (see below), a-thrombin, 29 leukotriene B4, 25 and ATP (unpublished data from this laboratory, 1993). In contrast, the [Ca 2+ ]j transient in response to the receptor-independent calcium elevating ionophore A 23187 was not inhibited by SK&F 96365, indicating that the blocking action is mediated by a receptor-coupled mechanism. Taken together, at the chosen concentration of 25 /imol/L, SK&F 96365 blocks receptor-operated calcium entry in ECs without significantly altering intracellular calcium release.
EDRF formation by ECs in response to stimulation with histamine depends mainly on activation of an agonist-induced calcium entry. This influx and the subsequent EDRF release was sensitive to SK&F 96365. 12 In bovine aortic ECs, EDRF and PGI 2 formation were found to be differentially regulated. After stimulation with bradykinin, EDRF production was completely dependent on extracellular calcium, whereas approximately 40% of prostacyclin could still be released in the absence of extracellular calcium. 11 Stimulation of ECs with histamine leads to a G protein-coupled activation of phospholipase C, which induces formation of InsP 3 .
HIstamine Hlstamlne
The InsP 3 production is closely linked to PGI 2 synthesis. 30 In the current study, 25 jtmol/L SK&F 96365 reduced histamine-induced calcium influx by approximately 82% and formation of prostacyclin by approximately 84%. It appears, therefore, that the remaining 16% of prostacyclin was released due to the incomplete inhibition of calcium influx. Alternatively, since some prostacyclin was formed in calcium-free buffer (approximately 13%), calcium released from internal stores via InsP 3 might have contributed to prostacyclin synthesis. In contrast, the calcium channel blocker nitrendipine had no effect on prostacyclin release, confirming the well-known observation that voltage-dependent calcium influx is not involved in prostanoid formation in ECs.
Some agonists that stimulate prostacyclin release in ECs concomitantly increase the production of TXA 2 , a potent vasoconstrictor and activator of platelets. 6 The (patho)physiological relevance of this phenomenon is not clear, but it may depend on the relative amounts, potencies, and kinetics of both prostanoids released. To address this question, we examined a potential proaggregatory effect of TXA 2 on platelets during coincubation. Compared with prostacyclin, only small amounts of TXA 2 were released from histamine-activated ECs. The release of TXA 2 was also inhibited by SK&F 96365. No phosphorylation of either pleckstrin, the substrate of protein kinase C, or myosin light chain, the substrate of Ca 2+ /calmodulin-dependent myosin light chain kinase, could be observed. Since both proteins are markers of platelet activation, 31 we conclude that the TXA 2 concomitantly released with PGI 2 and EDRF from ECs is not biologically relevant. The possible platelet-activating effect of TXA 2 was prevented by the inhibitory effects of prostacyclin and EDRF, which also interact synergistically with each other. 32 Endothelium-derived prostacyclin and EDRF through elevation of cAMP and cGMP, respectively, inhibit platelet aggregation. 31 The two platelet proteins raplB and VASP are both substrates for cAMP-and cGMP-dependent protein kinases. 3335 Measurement of rap IB phosphorylation has been proposed as a biological marker for monitoring the actions of labile platelet inhibitors that elevate cAMP (prostacyclin, iloprost) and cGMP (nitric oxide, SIN-1) in platelets. 33 Stimulation of venous ECs with histamine, and in a similar experimental design incubation of pig coronary artery rings with bradykinin, elicited a reversible phosphorylation of VASP and a long-lasting phosphorylation of raplB. Inhibition of prostanoid synthesis by indomethacin and of EDRF formation by L-NMMA markedly reduced the phosphorylation of both platelet proteins, indicating that endothelium-derived prostacyclin and EDRF were biologically active in these experiments. Blockade of receptor-mediated calcium entry in ECs by SK&F 96365 potently inhibited the phosphorylation of raplB and VASP. Its effect was as pronounced as the combined effects of indomethacin and L-NMMA, suggesting that inhibition of prostacyclin and EDRF by SK&F 96365 occurred in parallel through blockade of receptor-mediated calcium entry in human ECs.
In conclusion, the results emphasize the dependency of receptor-operated calcium influx and the requirement of extracellular calcium ions for the endothelial synthesis of biologically active prostacyclin and EDRF. In vivo, both mechanical alterations of the vessel wall (shear stress) and various locally generated and/or circulating mediators, eg, histamine and bradykinin, evoke calcium fluxes across the cell membrane, 8 thereby contributing to basal autacoid formation of ECs. Thus, pharmacological substances that inhibit agonist-induced calcium entry may attenuate the release of prostacyclin and EDRF from the endothelium.
